Rockwell Medical, Inc.RMTINASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

16 analysts·Moderate coverage

63%

Rating Distribution

Strong Buy

00%

Buy

1063%

Hold

213%

Sell

425%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 163% higher.

Bear Case

$3.00

+163%

Consensus

$3.00

+163%

Bull Case

$3.00

+163%

Price Range16 analysts

Low

Consensus

High

$3.00

Current Target

Current Price

$1.14

Upside to Target

$1.86

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.06(1 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+3.68%

EPS—

FY2028

Rev-2.97%

EPS—

FY2029

Rev+7.94%

EPS+250.00%

Earnings Surprises

Beat rate:58%(7/12 quarters)

Avg surprise:+44.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Mar 24, 2025H.C. Wainwright

Rockwell Medical price target lowered to $3 from $7 at H.C. Wainwright

Target:$3.00

+138.1%from $1.26

Sep 4, 2024H.C. Wainwright

H.C. Wainwright Reiterates Buy Rating on Rockwell Medical Technologies (RMTI)

Target:$9.00

+181.9%from $3.19

Jul 17, 2023H.C. Wainwright

Rockwell Medical On Course To Reach Profitability By Late 2024, Analyst Says

Target:$11.00

+162.5%from $4.19

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance